Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy

Detalles Bibliográficos
Autores principales: Bezerra, Evandro D., Iqbal, Madiha, Munoz, Javier, Khurana, Arushi, Wang, Yucai, Maurer, Matthew J., Bansal, Radhika, Hathcock, Matthew A., Bennani, Nora, Murthy, Hemant S., Rosenthal, Allison C., Paludo, Jonas, Villasboas, Jose C., Johnston, Patrick B., Habermann, Thomas M., Ansell, Stephen M., Castro, Januario E., Witzig, Thomas E., Kharfan-Dabaja, Mohamed A., Nowakowski, Grzegorz S., Lin, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139860/
https://www.ncbi.nlm.nih.gov/pubmed/36219588
http://dx.doi.org/10.1182/bloodadvances.2022007868
Descripción
Sumario:

Ejemplares similares